Mary Maha

856 total citations
7 papers, 639 citations indexed

About

Mary Maha is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mary Maha has authored 7 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Mary Maha's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Mary Maha is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Mary Maha collaborates with scholars based in United States and Malaysia. Mary Maha's co-authors include Philip A. Pizzo, Sandra Nusinoff-Lehrman, Samuel Broder, Pim Brouwers, Marc Rubin, Robert Yarchoan, Paul Jarosinski, Arturo Brunetti, Frank M. Balis and Howard B. Moss and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and The American Journal of Medicine.

In The Last Decade

Mary Maha

7 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Maha United States 6 499 437 212 97 35 7 639
Valerio Tozzi Italy 10 261 0.5× 296 0.7× 84 0.4× 128 1.3× 18 0.5× 21 395
C Leport France 7 219 0.4× 160 0.4× 138 0.7× 124 1.3× 28 0.8× 31 428
Marie‐Jeanne Mayaux France 9 393 0.8× 364 0.8× 155 0.7× 110 1.1× 88 2.5× 12 523
Rebekah Puls Australia 16 421 0.8× 425 1.0× 109 0.5× 157 1.6× 88 2.5× 26 639
Amy Krambrink United States 10 477 1.0× 547 1.3× 118 0.6× 162 1.7× 102 2.9× 15 655
Laura Bracciale Italy 13 387 0.8× 414 0.9× 154 0.7× 188 1.9× 17 0.5× 21 584
F Müller Switzerland 4 170 0.3× 268 0.6× 114 0.5× 58 0.6× 79 2.3× 5 359
Laura Zamora Spain 9 410 0.8× 310 0.7× 233 1.1× 37 0.4× 122 3.5× 19 669
J. L. Blanco Spain 12 451 0.9× 380 0.9× 139 0.7× 198 2.0× 25 0.7× 15 666
G. Friedland United States 11 315 0.6× 169 0.4× 323 1.5× 52 0.5× 30 0.9× 14 534

Countries citing papers authored by Mary Maha

Since Specialization
Citations

This map shows the geographic impact of Mary Maha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Maha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Maha more than expected).

Fields of papers citing papers by Mary Maha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Maha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Maha. The network helps show where Mary Maha may publish in the future.

Co-authorship network of co-authors of Mary Maha

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Maha. A scholar is included among the top collaborators of Mary Maha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Maha. Mary Maha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
McKinney, Ross E., Mary Maha, Edward M. Connor, et al.. (1991). A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease. New England Journal of Medicine. 324(15). 1018–1025. 156 indexed citations
2.
McKinney, Ross E., Philip A. Pizzo, Gwendolyn B. Scott, et al.. (1990). Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. The Journal of Pediatrics. 116(4). 640–647. 49 indexed citations
3.
Hollander, Harry, Alan R. Lifson, Mary Maha, et al.. (1989). Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals☆. The American Journal of Medicine. 87. 628–632. 2 indexed citations
4.
Hollander, Harry, et al.. (1989). Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals. The American Journal of Medicine. 87(6). 628–632. 15 indexed citations
5.
Falloon, Judith, Frank M. Balis, R.F. Murphy, et al.. (1989). Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. International Journal of Gynecology & Obstetrics. 28(4). 394–394. 17 indexed citations
6.
Pizzo, Philip A., Janie Eddy, Frank M. Balis, et al.. (1988). Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV Infection. New England Journal of Medicine. 319(14). 889–896. 343 indexed citations
7.
Surbone, Antonella, Robert Yarchoan, Martin Blum, et al.. (1988). Treatment of the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex with a Regimen of 3′-Azido-2′,3′-Dideoxythymidine (Azidothymidine or Zidovudine) and Acyclovir. Annals of Internal Medicine. 108(4). 534–540. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026